Study at a glance
What did studies of combined vitamin D and K supplements examine?
This page summarises human studies of vitamin D and vitamin K taken together. The two vitamins have connected biological roles, but that does not guarantee the same benefit for everyone. The key distinction is between improving a blood marker and improving bone structure or slowing unwanted calcium deposits.
What did studies of vitamins D and K find about bones?
Some trials in women with osteoporosis after menopause found improved bone mineral density with combined vitamin D and K2. Adding K2 to vitamin D and calcium also reduced the amount of incompletely processed osteocalcin, a bone protein. A review combining eight trials found similar improvements, although doses, participants and treatment designs differed. These findings apply to the populations and outcomes studied.
Did other studies show a general benefit from vitamins D and K?
A separate analysis of the VITAL trial found that better vitamin K status at the start did not predict better bone-density or bone-structure changes over two years. It also did not change the effect of vitamin D supplementation on bone density. In a two-year trial in men with calcium buildup in the aortic heart valve, vitamin K2 plus vitamin D improved a marker of inactive vitamin K-dependent protein. However, valve calcium buildup did not slow significantly compared with an inactive treatment.
Does everyone need vitamin K alongside vitamin D?
Combined treatment can change protein markers, and some bone studies found benefits. Those findings do not establish protection against bone loss or calcium buildup for everyone. Results depend on the population and the outcome measured. The evidence does not make vitamin K a universal requirement alongside vitamin D, or show that it protects against vitamin D toxicity and high blood calcium.
Read the full article below ↓Vitamin D and vitamin K have complementary mechanisms, but human trials show that combined supplementation does not produce one uniform bone or vascular outcome. Some osteoporosis studies report better bone mineral density and stronger reductions in undercarboxylated osteocalcin when vitamin K is added to vitamin D. More recent evidence shows that favourable changes in vitamin-K-dependent protein markers can occur without preventing bone loss or slowing established vascular calcification. This distinction is essential to interpreting Vitamin D and Vitamin K. For the detailed evidence review, see Combined Vitamin D and Vitamin K Supplementation for Bone and Vascular Markers: Full Study.
Bone studies show a signal in selected populations
Randomized studies in postmenopausal osteoporosis have reported increased lumbar-spine bone mineral density with combined vitamin D and K₂. Adding vitamin K₂ to vitamin D and calcium has also reduced undercarboxylated osteocalcin.
A meta-analysis of eight randomized trials found higher total BMD and lower undercarboxylated osteocalcin with combined vitamin K and vitamin D, although studies differed in dose, population and treatment design.
VITAL found no vitamin K modification of the vitamin D bone response
A 2026 VITAL ancillary analysis found that higher baseline vitamin K status did not predict favourable two-year changes in bone density or architecture and did not modify the effect of vitamin D supplementation on BMD.
This means the earlier positive osteoporosis trials cannot be generalized into a rule that adequate vitamin K makes vitamin D protect bone in all adults. The wider skeletal context is covered in Vitamin D and Bone.
Vascular biomarkers can improve without slowing calcification
In a two-year randomized trial of men with aortic-valve calcification, MK-7 plus vitamin D substantially reduced inactive dp-ucMGP. Despite that biochemical effect, aortic-valve calcification progression did not differ significantly from placebo.
This separates improved vitamin-K-dependent protein status from a structural vascular outcome. It also prevents the claim that combined supplementation has been proved to protect against vascular calcification.
The defensible conclusion
Vitamin D and vitamin K can interact physiologically, and combined treatment can alter bone and vascular biomarkers. Clinical outcomes remain population: and endpoint-dependent.
Vitamin K should therefore not be presented as a universal requirement alongside vitamin D or as protection against Vitamin D Toxicity and Hypercalcaemia.
Scientific sources
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. PMID: 32219282.
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL. PMID: 42524357.
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. PMID: 35465686.
Related reading
Bone metabolism during strict head-down tilt bed rest and exposure to elevated levels of ambient CO2
Astronauts on the International Space Station are exposed to levels of atmospheric carbon dioxide (CO2) above typical terrestrial levels.
Original paper ↗Read more →Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients
The aim of the study was to determine whether phosphocalcic markers are associated with, and can predict, renal chronic histological changes.
Original paper ↗Read more →Combined Vitamin D and Vitamin K Supplementation for Bone and Vascular Markers: Full Study
Randomized evidence on combined vitamin D and vitamin K supplementation for bone density, osteocalcin, MGP and vascular calcification markers.
Read more →Vitamin D and Vitamin K in Calcium Handling, Bone and Vascular Physiology: Evidence Synthesis
Evidence synthesis integrating vitamin D, vitamin K-dependent proteins, calcium handling, bone outcomes and vascular calcification evidence.
Read more →Low Bone Mineral Density and Calcium Levels as Risks for Mortality in Patients with Self-Discontinuation of Anti-Osteoporosis Medication
This study aimed to investigate the relationship between mortality and low BMD of the femoral neck and vertebra among patients self-discontinuing anti-osteoporosis medication.
Original paper ↗Read more →Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures
Compared to placebo, MSDK treatment increased BMD in lumbar spine (4.3%) and left femoral neck (2.2%), with an upward trend for total left hip (p=0.069).
Original paper ↗Read more →Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients
This study investigated whether or not vitamin D and calcium supplementation affected bone metabolism and bone mineral density (BMD) over a period of four years of denosumab therapy in patients with primary osteoporosis.
Original paper ↗Read more →Association of bone metabolic markers, bone mineral density and clinical characteristics with the occurrence of secondary fractures after PVP/PKP for osteoporotic thoracolumbar fractures: a study on logistic
A retrospective study was conducted on 107 OTF patients treated in our hospital from May 2023 to May 2024.
Original paper ↗Read more →Computed tomography-measured trabecular attenuation at first lumbar vertebra as a surrogate marker of bone mineral density and osteoporosis in patients undergoing hemodialysis
We examined the association between computed tomography (CT)-measured trabecular attenuation at the first lumbar vertebra (L1 CT-attenuation), bone mineral density (BMD), and osteoporosis in patients on hemodialysis.
Original paper ↗Read more →Dapagliflozin combined with metformin improves blood glucose, bone metabolism and bone mineral density in elderly patients with type 2 diabetes mellitus complicated with osteoporosis
We investigated the clinical efficacy of combining dapagliflozin with metformin in elderly patients with T2DM‐OP.
Original paper ↗Read more →Effects of Combined Exercise and Calcium/Vitamin D Supplementation on Bone Mineral Density in Postmenopausal Women: A Systematic Review and Meta-Analysis
Background: Postmenopausal osteoporosis (PMO) is a major cause of fragility fractures worldwide.
Original paper ↗Read more →Effects of Eggshell Calcium: and Vitamin D-Fortified HMR Combined with Aerobic Exercise on Bone Mineral Density in Postmenopausal Women: A Pilot Randomized Controlled Trial
Background/Objectives: Adequate calcium and vitamin D intake, along with regular physical activity, is essential for maintaining skeletal health in postmenopausal women.
Original paper ↗Read more →Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study
Here, the two sequential strategies were evaluated in severe osteoporotic patients.
Original paper ↗Read more →Short-term anabolic agent and sequential therapy to improve bone mineral density and bone turnover markers in patients with osteoporotic hip fractures
This study aimed to evaluate the effectiveness of sequential therapy using short-term anabolic agents followed by antiresorptive treatment on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with osteoporotic hip fractures.
Original paper ↗Read more →Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea
We retrospectively evaluated 189 postmenopausal osteoporosis patients treated with denosumab for 12 months.
Original paper ↗Read more →Association of a history of gestational diabetes mellitus with osteoporosis, bone mineral density, and trabecular bone score in postmenopausal women
The aim of this study was to investigate the association of a history of GDM with osteoporosis, BMD, and trabecular bone score (TBS) in postmenopausal women.
Original paper ↗Read more →Association of dietary carbohydrate and fiber ratio with postmenopausal bone mineral density and prevalence of osteoporosis: A cross-sectional study
This study aimed to investigate the associations of carbohydrate to dietary fiber ratio with bone mineral density (BMD) and the prevalence of osteoporosis in postmenopausal women.
Original paper ↗Read more →Association of the Dietary Inflammatory Index with bone mineral density and osteoporosis among adults with type 2 diabetes
DII scores were computed from 22 dietary components; participants lacking BMD or DII data were excluded.
Original paper ↗Read more →Clinical and Laboratory Predictors of Bone Mineral Density Trajectories and Osteoporosis Progression: A Retrospective Longitudinal Cohort Study
This study examined BMD trajectories and incident osteoporosis in a Saudi dual-energy X-ray absorptiometry (DXA) cohort.
Original paper ↗Read more →Type 2 Diabetes Mellitus and Osteoporosis: Site-Specific Bone Mineral Density Variations and Metabolic Correlations in Postmenopausal Saudi Women
Background and Objectives: Osteoporosis (OP) is a prevalent condition among postmenopausal women, with an estimated 40% of Saudi women affected.
Original paper ↗Read more →Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
Women in the tertile of the highest increase in 25(OH)D level showed a 5.7% BMD gain at lumbar spine, that was twice as great in comparison with participants with a lower 25(OH)D variation.
Original paper ↗Read more →Original sources
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials.
Publication details
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. PMID: 32219282.
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
Publication details
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL. PMID: 42524357.
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
Publication details
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. PMID: 35465686.